There is a vaccine for hepatitis A (see below, vaccine and prevention). If you have been exposed to someone who is infected with HAV, a treatment called immune serum globulin is available and may prevent you from becoming infected. Immune serum globulin is more likely to be effective when g...
Hep B vaccine hopeFocuses on the study conducted by Scottish researchers on the acceptability of hepatitis B vaccination of school children in Great Britain.Pulse
If you’re going to a country where hepatitis A is common and you’ve never had the virus or the vaccine, start the vaccination process as soon as you can. It takes 2-4 weeks after the first dose for the vaccine to work, but even one shot a few days before you leave will give y...
The results of the study of the reactogenicity, safety and immunological activity of Russian cultural vaccine against hepatitis A are presented. The vaccine was found to have specific safety, moderate reactogenicity and pronounced immunological activity. In addition, the study of the prophylactic efficien...
We assessed the safety and immunogenicity of a fully liquid, DTPw-HepB-Hib combination vaccine (Quinvaxem) in comparison with separately administered DTPw-Hib and hepatitis B vaccines. Infants participating in this open-label, randomized, phase II study received a primary vaccination course using a...
Syed1 Published online: 23 August 2019 © Springer Nature Switzerland AG 2019, corrected publication 2019 Abstract Hexyon® is a fully-liquid, ready-to-use, hexavalent vaccine approved in the EU since 2013 for primary and booster vac- cination in infants and toddlers...
II study, the safety and immunogenicity of a fully liquid diphtheria–tetanus–whole cell pertussis–hepatitis B–Haemophilus influenzae type b (DTPw–HepB–Hib) combination vaccine (Quinvaxem®) were assessed in infants who had or had not received a birth dose of hepatitis B (HepB) vaccine...
A large number of countries have recognized the value of combination vaccines and have introduced whole cell pentavalent vaccines into their immunization programs. A phase III, multi-center, randomized, single blinded study of a fully liquid pentavalent DTwP-HepB-Hib investigational vaccine (Shan5) ...
IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071IMMUNOGENICITY AND REACTOGENICITY IN INFANTS IMMUNISED WITH A NEW PENTAVALENT(DTwP-Hib-Hep B) VACCINE. |[utrif]| 1071Pediatric Research publishes original papers, invited reviews, an...
No articles found. Citing articles (0) This article has not been cited. Related book content No articles found.Download PDFsdoi:10.1016/j.vaccine.2009.04.060Karin A. WiedenmayerSvenjaWeissChandon ChattopadhyayAjoy MukherjeeRitabrata KunduRaffael AyéFabrizio TediosiManuel W. HetzelMarcel Tanner...